PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Small Cell Lung Cancer · Small Cell Lung Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Mark Dunphy, DO) · 212-639-8131

Study leads

Mark P Dunphy, DO
Principal Investigator
Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

Small Cell Lung Cancer (SCLC) · SCLC, Extensive Stage

Abroad (travel likely)RecruitingPHASE2

Tianjin, China

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Lexington, United States · Houston, United States

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · Los Angeles, United States

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Non-small Cell Lung Cancer Stage III · Non-small Cell Lung Cancer Stage IV · Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Cleveland, United States